PDEX (Pro-Dex Inc New) Stock Analysis - SEC Filings

Pro-Dex Inc New (PDEX) is a publicly traded Healthcare sector company. As of May 21, 2026, PDEX trades at $63.59 with a market cap of $188.88M and a P/E ratio of 18.23. PDEX moved +2.55% today. Year to date, PDEX is +63.92%; over the trailing twelve months it is +42.41%. Its 52-week range spans $23.47 to $70.26. Rallies surfaces PDEX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find PDEX SEC filings?

Rallies organizes PDEX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

PDEX Key Metrics

Key financial metrics for PDEX
MetricValue
Price$63.59
Market Cap$188.88M
P/E Ratio18.23
EPS$3.48
Dividend Yield0.00%
52-Week High$70.26
52-Week Low$23.47
Volume2
Avg Volume0
Revenue (TTM)$72.10M
Net Income$2.52M
Gross Margin28.29%

Latest PDEX News

Recent PDEX Insider Trades

  • CABILLOT RAYMOND E sold 7.26K (~$363.22K) on Apr 1, 2025.
  • CABILLOT RAYMOND E sold 836 (~$41.80K) on Mar 31, 2025.
  • CABILLOT RAYMOND E sold 842 (~$42.10K) on Mar 28, 2025.

PDEX Analyst Consensus

PDEX analyst coverage data. Average price target: $0.00.

Common questions about PDEX

Where can I find PDEX SEC filings?
Rallies organizes PDEX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show PDEX 10-K and 10-Q filings?
Rallies organizes PDEX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is PDEX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PDEX. It does not provide personalized investment advice.
PDEX

PDEX